866-997-4948(US-Canada Toll Free)

United States Drugs for Prostate Cancer Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Cancer

No. of Pages : 95 Pages

Notes:
Sales, means the sales volume of Drugs for Prostate Cancer
Revenue, means the sales value of Drugs for Prostate Cancer

This report studies sales (consumption) of Drugs for Prostate Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Drugs for Prostate Cancer in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Drugs for Prostate Cancer Market Report 2017
1 Drugs for Prostate Cancer Overview
1.1 Product Overview and Scope of Drugs for Prostate Cancer
1.2 Classification of Drugs for Prostate Cancer
1.2.1 Type I
1.2.2 Type II
1.3 Application of Drugs for Prostate Cancer
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Drugs for Prostate Cancer (2012-2022)
1.4.1 United States Drugs for Prostate Cancer Sales and Growth Rate (2012-2022)
1.4.2 United States Drugs for Prostate Cancer Revenue and Growth Rate (2012-2022)

2 United States Drugs for Prostate Cancer Competition by Manufacturers
2.1 United States Drugs for Prostate Cancer Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drugs for Prostate Cancer Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drugs for Prostate Cancer Average Price by Manufactures (2015 and 2016)
2.4 Drugs for Prostate Cancer Market Competitive Situation and Trends
2.4.1 Drugs for Prostate Cancer Market Concentration Rate
2.4.2 Drugs for Prostate Cancer Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Drugs for Prostate Cancer Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Drugs for Prostate Cancer Sales and Market Share by States (2012-2017)
3.2 United States Drugs for Prostate Cancer Revenue and Market Share by States (2012-2017)
3.3 United States Drugs for Prostate Cancer Price by States (2012-2017)

4 United States Drugs for Prostate Cancer Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Drugs for Prostate Cancer Sales and Market Share by Type (2012-2017)
4.2 United States Drugs for Prostate Cancer Revenue and Market Share by Type (2012-2017)
4.3 United States Drugs for Prostate Cancer Price by Type (2012-2017)
4.4 United States Drugs for Prostate Cancer Sales Growth Rate by Type (2012-2017)

5 United States Drugs for Prostate Cancer Sales (Volume) by Application (2012-2017)
5.1 United States Drugs for Prostate Cancer Sales and Market Share by Application (2012-2017)
5.2 United States Drugs for Prostate Cancer Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Drugs for Prostate Cancer Manufacturers Profiles/Analysis
6.1 Bristol-Myers Squibb
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bristol-Myers Squibb Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca
6.2.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly
6.3.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Roche
6.4.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Roche Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 GSK
6.5.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GSK Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Novartis
6.6.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Sanofi
6.8.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Bayer
6.9.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Bayer Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Celgene
6.10.2 Drugs for Prostate Cancer Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Celgene Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Drugs for Prostate Cancer Manufacturing Cost Analysis
7.1 Drugs for Prostate Cancer Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs for Prostate Cancer

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Drugs for Prostate Cancer Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs for Prostate Cancer Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Drugs for Prostate Cancer Market Forecast (2017-2022)
11.1 United States Drugs for Prostate Cancer Sales, Revenue Forecast (2017-2022)
11.2 United States Drugs for Prostate Cancer Sales Forecast by Type (2017-2022)
11.3 United States Drugs for Prostate Cancer Sales Forecast by Application (2017-2022)
11.4 Drugs for Prostate Cancer Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Drugs for Prostate Cancer
Table Classification of Drugs for Prostate Cancer
Figure United States Sales Market Share of Drugs for Prostate Cancer by Type in 2015
Table Application of Drugs for Prostate Cancer
Figure United States Sales Market Share of Drugs for Prostate Cancer by Application in 2015
Figure United States Drugs for Prostate Cancer Sales and Growth Rate (2012-2022)
Figure United States Drugs for Prostate Cancer Revenue and Growth Rate (2012-2022)
Table United States Drugs for Prostate Cancer Sales of Key Manufacturers (2015 and 2016)
Table United States Drugs for Prostate Cancer Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Prostate Cancer Sales Share by Manufacturers
Figure 2016 Drugs for Prostate Cancer Sales Share by Manufacturers
Table United States Drugs for Prostate Cancer Revenue by Manufacturers (2015 and 2016)
Table United States Drugs for Prostate Cancer Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drugs for Prostate Cancer Revenue Share by Manufacturers
Table 2016 United States Drugs for Prostate Cancer Revenue Share by Manufacturers
Table United States Market Drugs for Prostate Cancer Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drugs for Prostate Cancer Average Price of Key Manufacturers in 2015
Figure Drugs for Prostate Cancer Market Share of Top 3 Manufacturers
Figure Drugs for Prostate Cancer Market Share of Top 5 Manufacturers
Table United States Drugs for Prostate Cancer Sales by States (2012-2017)
Table United States Drugs for Prostate Cancer Sales Share by States (2012-2017)
Figure United States Drugs for Prostate Cancer Sales Market Share by States in 2015
Table United States Drugs for Prostate Cancer Revenue and Market Share by States (2012-2017)
Table United States Drugs for Prostate Cancer Revenue Share by States (2012-2017)
Figure Revenue Market Share of Drugs for Prostate Cancer by States (2012-2017)
Table United States Drugs for Prostate Cancer Price by States (2012-2017)
Table United States Drugs for Prostate Cancer Sales by Type (2012-2017)
Table United States Drugs for Prostate Cancer Sales Share by Type (2012-2017)
Figure United States Drugs for Prostate Cancer Sales Market Share by Type in 2015
Table United States Drugs for Prostate Cancer Revenue and Market Share by Type (2012-2017)
Table United States Drugs for Prostate Cancer Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Prostate Cancer by Type (2012-2017)
Table United States Drugs for Prostate Cancer Price by Type (2012-2017)
Figure United States Drugs for Prostate Cancer Sales Growth Rate by Type (2012-2017)
Table United States Drugs for Prostate Cancer Sales by Application (2012-2017)
Table United States Drugs for Prostate Cancer Sales Market Share by Application (2012-2017)
Figure United States Drugs for Prostate Cancer Sales Market Share by Application in 2015
Table United States Drugs for Prostate Cancer Sales Growth Rate by Application (2012-2017)
Figure United States Drugs for Prostate Cancer Sales Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table Celgene Basic Information List
Table Celgene Drugs for Prostate Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celgene Drugs for Prostate Cancer Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Prostate Cancer
Figure Manufacturing Process Analysis of Drugs for Prostate Cancer
Figure Drugs for Prostate Cancer Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Prostate Cancer Major Manufacturers in 2015
Table Major Buyers of Drugs for Prostate Cancer
Table Distributors/Traders List
Figure United States Drugs for Prostate Cancer Production and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Prostate Cancer Revenue and Growth Rate Forecast (2017-2022)
Table United States Drugs for Prostate Cancer Production Forecast by Type (2017-2022)
Table United States Drugs for Prostate Cancer Consumption Forecast by Application (2017-2022)
Table United States Drugs for Prostate Cancer Sales Forecast by States (2017-2022)
Table United States Drugs for Prostate Cancer Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *